Korenberg Matthew E
- SEC CIK
- 0001649903
No open-market purchases or sales filed in the past year.
Current role at each company
- PVLA Palvella Therapeutics, Inc.CFO, Treasureras of Jun 16, 2026
- LFCR Lifecore Biomedical, Inc. DEDirectoras of Jun 5, 2026
- LGND Ligand Pharmaceuticals IncPresident & COOas of Sep 24, 2024
- AIXC AIxCrypto Holdings, Inc.Directoras of Aug 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Korenberg Matthew E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LGND Ligand Pharmaceuticals Inc
President & COO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2024 (view filing) | Sep 20-23 | 4 days | Korenberg Matthew EPresident & COO | SSale | −16.0K | $102.35 | −$1.64M | −24.0%50.8K after | 4 lots |
| Aug 26, 2024 (view filing) | Aug 22-26 | 4 days | Korenberg Matthew EPresident & COO | SSale | −18.9K | $105.34 | −$1.99M | −27.6%49.5K after | 5 lots |
| Aug 13, 2024 (view filing) | Aug 9 | 4 days | Korenberg Matthew EPresident & COO | SSale | −18.2K | $98.50 | −$1.80M | −21.1%68.4K after | |
| May 15, 2024 (view filing) | May 13-14 | 2 days | Korenberg Matthew EPresident & Chief Operating | SSale | −17.6K | $84.99 | −$1.50M | −16.9%86.3K after | 3 lots |